Aggressive forecasts for the GLP-1 obesity market have caused no small amount of anxiety among insurers, employers and others nervous about managing this gathering tsunami.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,